Wissenschaftliche Publikationen des Krebsregisters Ostschweiz
The relative risk of second primary cancers in Switzerland: a population-based retrospective cohort study. Feller A, L. Matthes KL, Bordoni A, Bouchardy C, Bulliard J-L, Herrmann C, Konzelmann I, Maspoli M, Mousavi M, Rohrmann S, Staehelin K, Arndt V & the NICER Working Group. BMC Cancer. 2020 Jan. https://doi.org/10.1186/s12885-019-6452-0
Does progress achieved in the treatment of patients with metastatic non-small-cell lung cancer reach the elderly population? A cohort study from a cancer centre from Eastern Switzerland. Schmid S, Suipyte J, Herrmann C, Mousavi M, Hitz F, Früh M. European Journal of Cancer Care. 2020 Jan. https://doi.org/10.1111/ecc.13206
Comment on: Wieser et al. Ovarian cancer in Switzerland: incidence and treatment according to hospital registry data. Feller A, Bopp M, Lorez M, Zellweger U, Adam M, Curjuric I, Staehelin K, Perren A, Bergeron Y, Rapiti E, Mousavi M, Diebold J, Dyntar D, Bulliard J-L, Maspoli Conconi M, Bordoni A, Konzelmann I, Wagner U, Rohrmann S. Swiss Medical Weekly. 2020 Feb. https://doi.org/10.4414/smw.2020.20179
Incidence and Survival of Patients With Conjunctival Melanoma in Europe. Virgili G, Parravano M; Gatta G, Capocaccia R, Mazzini C, Mallone S, Botta L; for the RARECAREnetWorking Group. JAMA Ophtalmology. 2020 Mar. https://doi.org/10.1001/jamaophthalmol.2020.0531
Incidence and survival of rare cancers in the US and Europe. Botta L, Gatta G, Trama A, Bernasconi A, Sharon E, Capocaccia R, Mariotto AB, the RARECAREnet working group. Cancer Medecine. 2020 Apr. https://doi.org/10.1002/cam4.3137
Rare thyroid malignancies in Europe: Data from the information network on rare cancers in Europe (RARECAREnet). Locati L, Cavalieri S, Dal MasoL, Busco S, Anderson LA, Botta L, Bento MJ, Carulla M, Chirlaque López M D, Fusco M, Guevara M, Innos K, Johannesen TB, Micallef R, Minicozzi P, Panato C, Petrova D, Rubio-Casadevall J, Smailyte G, Vitale MF, Trama A, RARECAREnet Working Group. Oral Oncology. 2020 May. https://www.elsevier.com/locate/oraloncology
Health-Related Quality of Life in Long-Term Prostate Cancer Survivors after Nerve-Sparing and Non-Nerve-Sparing Radical Prostatectomy – Results from the Multiregional PROCAS Study. Adam S, Martin-Diener E, Camey B, Egger Hayoz C, Konzelmann I, Mousavi SM, Herrmann C, Rohrmann S, Wanner M, Staehelin K, Strebel R T, Randazzo M, John H, Schmid H-P, Arndt V. Cancer Medecine. 2020 Jun. https://doi.org/10.1002/cam4.3197
Identifying classes of the pain, fatigue and depression symptom cluster in long-term prostate cancer survivors – Results from the multiregional PROCAS study. Adam S, Thong MSY, Martin-Diener E, Camey B, Egger Hayoz C, Konzelmann I, Mousavi SM, Herrmann C, Rohrmann S, Wanner M, Staehelin K, Strebel RT, Randazzo M, John H, Schmid H-P, Feller A, Arndt V. Wäre an der 76. Jahresversammlung der Schweizer Gesellschaft für Urologie 2.-4.September 2020 vorgestellt worden. Poster PROCAS
Kaposi sarcoma incidence, survival and trends: Data from the information network on rare cancers in Europe (RARECAREnet) Stiller CA, Botta L, Sánchez Perez MJ, Chirlaque López MD, Marcos-Gragera R, Scuderi T, Huws DW, Trama A, the RARECARENet WG. Cancer Epidemiology. 2020 Dec. https://doi.org/10.1016/j.canep.2020.101877